We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » DOJ Charges Glenmark In Ongoing Generic Price-Fixing Investigation
DOJ Charges Glenmark In Ongoing Generic Price-Fixing Investigation
The Department of Justice (DOJ) has charged Indian drugmaker Glenmark Pharmaceuticals with allegedly conspiring to increase prices on the cholesterol drug pravastin.